HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing in Brief: X Body Talk

This article was originally published in The Rose Sheet

Executive Summary

X Body Talk: Unisex scent to be supported by a $2 mil. ad budget for the fourth quarter, with TV spots running on cable networks such as Black Entertainment Television and MTV, and print ads appearing in Rolling Stone and Vibe, according to Intercosmetic, the U.S. division of Wella Fragrances & Cosmetics Group. The "hip and cool" mass market scent is geared toward men and women ages 15 to 25, according to the company. Supplied by Firmenich, the fragrance opens with lime, geranium, galbanum, bergamot and marine notes, leading to a "fresh" heart of rose, jasmine, lavandin, cypress, carnation and clary sage. The "warm, sensual" and woody drydown comprises patchouli, sandalwood, musk and amber. Packaged in a clear, glass bottle with a grooved silver cap, a 3.4 oz. eau de toilette will be priced at $23...

You may also be interested in...



OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review
UsernamePublicRestriction

Register

RS004347

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel